“Importantly, it now excludes patients with severe pulmonary injury (low ration of atrial oxygen to inspired concentration of oxygen, even with high peep).”

When I have time, I’ll have to look at clinicaltrials.gov and see if these patients were excluded from treatment under the S/C protocol (I’m assuming not if the FDA made the recommendation for the open label extension).